Page last updated: 2024-10-26

etidronate and Stomach Neoplasms

etidronate has been researched along with Stomach Neoplasms in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Stomach Neoplasms: Tumors or cancer of the STOMACH.

Research Excerpts

ExcerptRelevanceReference
"Alendronate users had a lower risk of incident gastric cancer [odds ratio (OR) 0."1.38Esophageal and gastric cancer incidence and mortality in alendronate users. ( Abrahamsen, B; Eastell, R; Eiken, P; Pazianas, M; Russell, RG, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahamsen, B1
Pazianas, M1
Eiken, P1
Russell, RG1
Eastell, R1

Other Studies

1 other study available for etidronate and Stomach Neoplasms

ArticleYear
Esophageal and gastric cancer incidence and mortality in alendronate users.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2012, Volume: 27, Issue:3

    Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Denmark; Esophageal Neoplasms; Etidronic

2012